Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye

Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye

US Patent 8912236 · Granted Dec 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2023
Pharmaceutical compositions of lipoic acid choline ester salts and methods of tr2021
Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide der2019
Pharmaceutical suspension2017
Carboxylvinyl polymer-containing nanoparticle suspensions2017
Hydrometallurgical process for the recovery of tellurium from high lead bearing 2017
High concentration olopatadine ophthalmic composition2017
Finafloxacin suspension compositions2016
Finafloxacin suspension compositions2016
Aqueous pharmaceutical compositions containing borate-polyol complexes2016
Pharmaceutical compositions having desirable bioavailability2015
Aqueous pharmaceutical compositions containing borate-polyol complexes2015